Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday. The company traded as low as $13.14 and last traded at $13.34, with a volume of 210,253 shares trading hands. The stock had previously closed at $13.89.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on IPX shares. Jefferies Financial Group assumed coverage on IperionX in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $26.00 target price on the stock. Roth Capital set a $53.00 price objective on IperionX in a research note on Wednesday, August 5th. B. Riley Financial dropped their price target on IperionX from $52.00 to $34.00 and set a “buy” rating on the stock in a research report on Wednesday, September 30th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a report on Thursday, October 15th. Six analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $42.00.
Check Out Our Latest Stock Analysis on IPX
IperionX Stock Performance
The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.95 and a current ratio of 3.24. The firm has a 50-day moving average price of $18.96 and a 200-day moving average price of $26.63.
IperionX (NASDAQ:IPX – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported ($0.50) earnings per share for the quarter. As a group, research analysts expect that IperionX Limited Sponsored ADR will post -0.13 earnings per share for the current year.
Institutional Trading of IperionX
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Connective Capital Management LLC acquired a new position in shares of IperionX in the 2nd quarter worth $160,000. GAMMA Investing LLC raised its holdings in IperionX by 40.3% during the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock worth $50,000 after buying an additional 483 shares during the period. DLD Asset Management LP purchased a new stake in IperionX during the first quarter valued at about $260,000. Finally, Private Advisor Group LLC boosted its holdings in shares of IperionX by 69.9% in the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock worth $1,643,000 after buying an additional 25,964 shares during the period. 2.76% of the stock is owned by institutional investors and hedge funds.
IperionX Company Profile
IperionX Limited (NASDAQ: IPX) is a critical minerals and advanced materials company focused on producing low-carbon titanium products in the United States. The company is developing domestic sources of titanium minerals and technologies intended to convert titanium feedstocks into titanium metal, powder and other advanced materials.
IperionX’s primary development asset is the Titan Project in Tennessee, which contains titanium, zircon and other heavy mineral sands. The company is also developing proprietary processing technologies, including the Hydrogen-Assisted Metallothermic Reduction (HAMR) process and the Titanium Alloy Production (TAP) process, with the goal of manufacturing titanium products using less energy than conventional production methods and incorporating recycled titanium where practical.
The company targets customers in industries such as aerospace, defense, medical devices, automotive, consumer products and additive manufacturing.
Featured Stories
- Five stocks we like better than IperionX
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
